作者
John P. Sfakianos,Arnab Basu,George Laliotis,Shivaram Cumarasamy,Jordan Rich,Ajitha Kommalapati,Michael Glover,Tamara Mahmood,Neeraja Tillu,Christopher J. Hoimes,Grayce Selig,Revathi Kollipara,Tyler F. Stewart,Samuel Rivero-Hinojosa,Punashi Dutta,Mark Calhoun,Shruti Sharma,Meenakshi Malhotra,Adam C. ElNaggar,Minetta C. Liu,James E. Ferguson,Márcio A. Diniz,Reza Mehrazin,Peter Wiklund,Alan Tan,Sumit Shah,Matthew D. Galsky
摘要
Despite curative-intent radical cystectomy (RC), patients with muscle-invasive bladder cancer (MIBC) are at high risk of recurrence. Biomarkers are urgently needed to refine prognostication and selection of appropriate perioperative systemic therapies. Our aim was to evaluate the prognostic and predictive value of tumor-informed circulating tumor DNA (ctDNA) results in a multicenter cohort of patients with bladder cancer who underwent RC.